Jefferies Group LLC Global Blood Therapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $2.64 Million - $4.46 Million	-70,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $4.3 Million - $6.07 Million	-81,500 Reduced 53.8%	70,000 $3.86 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $721,204 - $1.21 Million	14,800 Added 10.83%	151,500 $9.56 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $5.02 Million - $10.5 Million	120,400 Added 738.65%	136,700 $6.98 Million
Q4 2019 Feb 13, 2020	SELL	$45.7 - $81.86 $1.02 Million - $1.83 Million	-22,300 Reduced 57.77%	16,300 $1.3 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $1.79 Million - $2.15 Million	34,000 Added 739.13%	38,600 $2.03 Million
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $915,771 - $1.22 Million	-22,900 Reduced 83.27%	4,600 $243,000
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $201,856 - $298,688	-6,400 Reduced 18.88%	27,500 $1.13 Million
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $915,800 - $1.23 Million	24,100 Added 245.92%	33,900 $1.29 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $379,260 - $491,470	9,800 New	9,800 $443,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.